Centrum 7/6  banner

CVS

CVS’ Q3 sales and profits beat forecasts

CVS’ Q3 sales and profits beat forecasts

WOONSOCKET, R.I. —  CVS Health topped Wall Street’s estimates for third quarter revenue and earnings. Adjusted earnings per share of $2.21 exceeded analysts’ predicted $2.13, while revenue of $89.76 billion beat  the forecast of $88.2 billion. “Our colleagues helped us deliver another quarter of positive results across our business areas,” said president and CEO Karen

CVS beats Q2 revenue and profit forecasts

CVS beats Q2 revenue and profit forecasts

WOONSOCKET, R.I. — CVS Health topped Wall Street’s estimates for the top and bottom lines for the second quarter ended June 30. Revenue, driven by growth across segments, rose 10.3% to $88.9 billion, exceeding analysts’ forecast of an $86.45 billion. While adjusted earnings dipped 12.6% from the year-ago period to $2.21 per share, they beat

CVS will buy renewable energy

CVS will buy renewable energy

WOONSOCKET, R.I. — CVS Health will purchase zero-emission, renewable energy from Constellation Energy Corp. equivalent to the annual electricity use of its 147 stores in Michigan. Through a 12-year agreement beginning in April 2025, CVS will buy energy and renewable energy certificates (RECs) from Swift Current Energy’s Double Black Diamond Solar Project in Illinois. This

CVS promotes Wier to VP of store brands

CVS promotes Wier to VP of store brands

WOONSOCKET, R.I. _ Michael Wier has been promoted to vice president of store brands at CVS Health. He had been executive director – divisional merchandise manager for consumer health and wellness since August 2020. “In this new role, I am looking forward to collaborating with our exceptional internal and external partners,” Wier wrote on LinkedIn.

CVS beats first quarter revenue and earnings projections

CVS beats first quarter revenue and earnings projections

WOONSOCKET, R.I. — CVS Health posted first quarter sales and earnings that topped Wall Street’s forecasts. Revenue for the period ended March 31 rose 11% to $85.3 billion, exceeding analysts’ projected $80.79 billion. Adjusted earnings of $2.20 per share beat the average estimate of $2.09. The strong showing notwithstanding, the company lowered its outlook for

CVS, Walmart to cut pharmacy hours amid labor concerns

CVS, Walmart to cut pharmacy hours amid labor concerns

NEW YORK — CVS Health and Walmart announced that they will be reducing pharmacy hours to address the ongoing pharmacist shortage, The Wall Street Journal reported Friday. CVS plans to cut or shift operating hours at about two-thirds of its 9,000-strong U.S. network in March, while Walmart intends to close most of its nearly 4,600

CVS, Walgreens limiting purchases of kids’ pain and fever medicines

CVS, Walgreens limiting purchases of kids’ pain and fever medicines

NEW YORK— Both CVS and Walgreens are limiting how many children’s pain and fever medications customers can buy — the latest sign that pharmacies are struggling to keep up with demand for basic cold and flu remedies, as respiratory illnesses spike nationwide. CVS is limiting customers to a “two product limit on all children’s pain

CVS completes rollout of time delay safes in 13 states

CVS completes rollout of time delay safes in 13 states

WOONSOCKET, R.I. – Amidst a busy holiday shopping season and as part of an ongoing commitment to support law enforcement and help build safer communities, CVS Health announced the installation of time delay safe technology in 800 CVS Pharmacy locations — including those in Target stores — in 13 states across the U.S. The states

CVS Health invests $14.3 million in affordable housing in Seattle

CVS Health invests $14.3 million in affordable housing in Seattle

WOONSOCKET, R.I. — CVS Health announced a $14.3 million investment with Chief Seattle Club and Raymond James Affordable Housing Investments to build 120 affordable housing units in Seattle, Washington as part of the company’s commitment to advancing health equity by addressing social determinants of health at the local level. “When people have access to high-quality

CVS beats Q3 sales and earnings forecasts by wide margin

CVS beats Q3 sales and earnings forecasts by wide margin

WOONSOCKET, R.I. — CVS Health easily beat analysts’ sales and earnings estimates for the third quarter and again raised its full year guidance. The company reported adjusted earnings per share $2.09 on revenue of $81.16 billion, which climbed 10% from a year earlier. Wall Street had expected adjusted EPS of $1.99 on revenue of $76.75

1 2 3 13
PP_1170x120_10-25-21